| Name | Title | Contact Details |
|---|
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Venus Laboratories Inc is a Wood Dale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.
For 25 years, Q'Straint has remained focused on one vision: to develop the world's most effective wheelchair passenger safety solutions for public and private transportation. Today, Q'Straint is a global company with a local network of representatives
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. With more than three decades of expertise in all areas of oncology practice management, AON enables physicians to focus on what matters most – providing the highest quality care for patients. We preserve and protect the sustainability of community oncology for physicians, patients and partners, so practices thrive. Ensure that every American has local access to exceptional cancer care. AON provides comprehensive administrative support and ancillary services that help community oncology practices thrive in an increasingly complex healthcare environment. Our collaborative approach and physician-led model allows practices to maintain local leadership and autonomy. With over three decades of successfully improving and advancing community oncology practices, we have developed a proven business model that allows practices to benefit from our scale and expertise in such critical areas as drug-procurement and payer contracting, as well as practice diversification through central lab and pathology, specialty pharmacy. AON was created and is led by the leadership team responsible for the success of Florida Cancer Specialists & Research Institute, the nation`s largest independent community oncology practice. Our team has vast experience in complex and diverse group practice integration and is able to ensure a smooth and successful transition process for local practices that choose to become a part of the AON.